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A quantitative description of solute and fluid transport during perito-
neal dialysis. To investigate the relationship between dialysate glucose
concentration and peritoneal fluid and solute transport parameters, 41
six-hour single dwell studies with standard glucose-based dialysis fluids
containing 1.36% (N = 9), 2.27% (N = 9)and 3.86% (N = 23) anhydrous
glucose were carried out in 33 clinically-stable continuous ambulatory
peritoneal dialysis (CAPD) patients. Intraperitoneal dialysate volumes
(VD) were determined from the dilution of '3I-albumin with a correc-
tion applied for its elimination from the peritoneal cavity (KE, mI/mm).
Diffusive mass transport coefficients (K0) were calculated from aque-
ous solute concentrations (with a correction applied for the plasma
protein concentration and, for electrolytes, also for the Donnan factor)
during a period of dialysate isovolemia. The intraperitoneal amount
calculated to be transported by diffusion was subtracted from the
measured total amount of solutes in the dialysate, yielding an estimate
of non-diffusive solute transport. The intrapentoneal dialysate volume
over time curve was characterized by: initial net ultrafiltration (lasting
on average 92 mm, 160 mm and 197 mm and with maximum mean net
ultrafiltration rates 6 mI/mm, 8 mI/mm and 14 mI/mm, respectively, for
the 1.36%, 2.27% and 3.86% solutions); dialysate isovolemia (lasting
about 120 mm for all three solutions) and fluid reabsorption (rate about
1 mI/mm for all three solutions). KBD for glucose, potassium, creatinine,
urea and total protein did not differ between the three solutions and the
fractional absorption of glucose was almost identical for the three
glucose solutions, indicating that the diffusive transport properties of
the peritoneum is not influenced by the initial concentration of glucose
or the ultrafiltration flow rate. About 50% of the total absorption of
glucose occurred during the first 90 minutes of the dwell. The mean
percentage of the initial amount of glucose which had been absorbed
(%GA) at time t during the dwell could be described (r = 0.999) for all
three solutions using the experimental formula %GA 85 — 75.7 *
e_OOSt, After 360 minutes, about 75% of the initial mntraperitoneal
glucose amount had been absorbed corresponding to a mean (± SD)
energy supply of 75 6 keal, 13! 18 kcal and 211 26 kcal for the
three solutions. Non-diffusive (that is, mainly convective) transport was
almost negligible for the less hypertonic solutions while it was estimated
to account for 30 to 40% of the total peritoneal transport of urea,
creatinine and potassium during the first 60 minutes of the 3.86%
exchange.
Glucose is still the most widely used osmotic agent for
peritoneal dialysis, although alternative osmotic agents such as
glycerol U, 21, amino acids [3, 4] and glucose polymers [5] have
been investigated in small groups of patients. Three standard
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glucose solutions containing 1.36%, 2.27% and 3.86% of anhy-
drous dextrose/glucose are used in the majority of continuous
ambulatory peritoneal dialysis (CAPD) patients. Despite the
widespread use of glucose-based solutions, peritoneal solute
and fluid transport characteristics are still not well described for
standard dialysis solutions in CAPD. A detailed quantitative
analysis of fluid and solute transport parameters for these
solutions is of value for the clinical management of CAPD
patients using current solutions, as well as for the evaluation of
changes in treatment strategies such as the introduction of new
osmotic agents.
During peritoneal dialysis solutes are transported through the
peritoneal barrier both by diffusion (due to the concentration
gradient between blood and dialysate) and by convection (due
to the osmotic dysequilibrium caused by the osmotic agent).
Diffusion is the main transport mechanism [61 although the use
of hypertonic dialysis solutions may result in substantial con-
vective transport [6, 71. However, the relative importance of
diffusive and convective transport for different solutions has as
yet not been established in detail. A variety of models based on
the theory of transport across the homogeneous membrane are
available for the mathematical description of the diffusive and
convective components of peritoneal transport [6, 8—13]. How-
ever, the determination of the convective component using
these models is associated with difficulties in the physiological
interpretation of the convective transport parameter, sieving
coefficient, which has been found to be outside the physiolog-
ical acceptable range for several investigated small solutes [12].
We have previously applied an alternative method (isovolu-
metric method) to evaluate the diffusive transport parameter [2,
3, 12, 14]. An advantage with this method, which was applied in
the current study, is that it does not require any assumptions
concerning the theoretical description of convective peritoneal
transport [2, 3, 12, 14]. However, it should be noted that
dialysate isovolemia indicates zero ultrafiltration through the
peritoneal membrane only under the premises that lymphatic
absorption and recirculation of water between blood and dial-
ysate are negligible.
The continuous glucose absorption from the dialysate during
CAPD treatment (with a positive glucose gradient existing even
after a dwell time of six hours with 1.36% glucose solution [151)
results in a unique metabolic situation in which the patient is
never in a true fasting state. This is of importance for the
nutritional status of the patients since glucose absorption may
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Table 1. Patient characteristics for three groups of patients undergoing single dwell studies with 1.36%, 2.27% and 3.86% glucose dialysis
solution, respectively
N
Age
years
TCAPD
months
Body
kg
wt PIT
N V24 hr
Diagnosis
ml! CGN IN PKD Other
1.36% 9 61 8 26 19 62 10 1.3 1.2 117 277 3 2 3 1
2.27% 9 60 7 23 14 63 II 1.7 3.2 157 190 3 2 4 —
3.86% 23 57 12 16 17 66 15 1.3 2.9 151 262 12 5 2 4
Data are means SD. Abbreviations are: TCAPD, time on CAPD treatment; PIT, number of previous peritonitis episodes; V, urine volume;
CGN, chronic glomerulonephritis; IN, interstitial nephritis!chronic pyelonephritis; PKD, polycystic kidney disease. Statistical analysis (ANOVA)
showed no significant difference between the three groups.
serve as an important source of energy. However, glucose
absorption may also contribute to adverse metabolic effects
such as hyperlipidemia, hyperglycemia, hyperinsulinemia and
obesity [16, 17]. Thus, studies on peritoneal glucose transport
are of importance for the investigation of metabolic effects of
CAPD.
The aim of this study was to evaluate peritoneal solute and
fluid transport for the three most widely used, standard glucose-
based solutions in order to characterize differences in fluid
transport patterns and to assess the possible influence of
different dialysate glucose concentrations on diffusive mass
transport coefficients. The isovolumetric method, which is
based on the assumption that the impact of convective solute
transport during dialysate isovolemia is negligible, is not di-
rectly applicable to assess convective solute transport. There-
fore, to quantitatively assess the relative importance of diffu-
sive versus non-diffusive peritoneal transport of solutes, the
total amount of solutes transported to the dialysate was mea-
sured and compared with the calculated amount that would
have been transported if diffusion had been the only transport
mechanism.
Methods
Patients
A total of 41 six-hour dwell studies, with standard dialysis
fluid containing glucose as osmotic agent (anhydrous glucose of
1.36%, 2.27% and 3.86%, respectively) were performed in 33
CAPD patients using a uniform study protocol (see below).
Note that the concentrations correspond to 1.5%, 2.5% and
4.25% hydrous glucose, respectively, as the solutions usually
are quoted in the United States. Nine patients were studied with
1.36% glucose dialysis fluid, nine patients with 2.27% glucose
dialysis fluid and 23 patients with 3.86% glucose dialysis fluid.
Two patients were studied with all three glucose concentra-
tions, four patients were studied with two different concentra-
tions and 27 patients were studied with one of the solutions. The
dwell studies were made as part of the routine clinical follow-up
of the patients or as part of studies of alternative osmotic agents
[2, 3].
The clinical characteristics of the patients and the etiology of
endstage renal disease are given in Table 1. None of the patients
had diabetes mellitus, or vascular disease such as vasculitis
known to influence capillary transport. The patients had mini-
mal residual renal function (Table 1) and had been treated with
CAPD for 0.5 to 65 months prior to the study. None of the
patients had been treated with recombinant human erythropoi-
etin, and their mean SD hemoglobin level was 95 17 g/liter.
All patients had been free from peritonitis for at least one month
prior to the study. Sixteen patients had had no peritonitis
episodes and in the other 17 patients the peritonitis free interval
before the study was 1 to 32 months. A small but statistically
significant difference in the diffusive mass transport coefficient,
KBD, was seen between the patients with and without previous
peritonitis episodes (Results). All patients were in a clinically
stable condition with no signs of impaired peritoneal ultrafiltra-
tion capacity.
Dialysis technique
CAPD was performed according to standard methods using
glucose-based solutions with lactate as a buffer [18]. During the
week preceding the study, the patients used a mean number of
3.9 exchanges per day; the average SD glucose concentration
used (calculated as the total amount of glucose in the bags per
day divided by the total volume of dialysis fluid instilled per
day) did not differ between the three groups (2.40 0.43mg/mi,
2.31 0.30 mg/mi, and 2.43 0.37 mg/mI for the 1.36%, 2.27%
and 3.86% solution groups, respectively).
Study protocol
The six-hour dwell study was carried out with 2 liters of
glucose 1.36%, 2.27% or 3.86% dialysis fluid (Dianeal, Baxter-
Travenol, Deerfield, Illinois, USA or Halden, Norway) sup-
plied in plastic bags (Viaflex, Baxter-Travenol). The electrolyte
and buffer concentrations were: sodium 132, calcium 1.75,
magnesium 0.75, chloride 102, and lactate 35, all in mmol/liter.
The measured glucose concentration in the fresh dialysis fluid
was 73 3 mmol/liter, 121 5 mmol/liter and 209 6
mmoL/liter for the 1.36%, 2.27% and 3.86% solution, respec-
tively. The total osmolality of the dialysate was 334 6
mOsmol/kg, 380 10 mOsmol/kg and 479 6 mOsmol/kg for
the three solutions, respectively.
The patients were studied in the morning after an overnight
oral fast. Overnight dialysate, which was instilled at about 10:00
p.m. in the evening before the study (Dianeal glucose 1.36% in
all except two cases in which Diarieal glucose 2.27% was used)
was drained at 7:15 a.m. Fresh dialysis fluid (Dianeal glucose
1.36%, 2.27% or 3.86%) was prewarmed to 37°C and prepared
with a priming dose of 0.2 g of human serum albumin to
minimize the adhesion of the tagged albumin to the surface of
the plastic material. Radioisotopically labelled albumin [185
kBq '311-human serum albumin (RISA), Institutt for Energ-
iteknikk, Kjeller, Norway] was added and the fluid was then
infused through an infusion set (CAPD Solution Transfer-set,
Travenol Laboratories). Fresh dialysis fluid samples were taken
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from the bag halfway through infusion. Dialysate samples (15
ml) were taken through a three-way stop-cock (Viggo, Con-
necta, Helsingborg, Sweden) and an indwelling permanent
Tenckhoff catheter at 3, 15, 30, 60, 90, 120, 180, 240, and 360
minutes after the complete infusion of the dialysis fluid. Prior to
each sampling, 10 ml of the dialy sate was flushed back and forth
five times through the stop-cock. Blood samples were drawn at
0, 180 and 360 minutes (0, 30, 60, 180, 240, and 360 mm for
determination of glucose in most patients). After 360 minutes,
the dialysate was drained and the volume recorded. The pen-
toneal cavity was then rinsed for five minutes with 1 liter of
fresh 1.36% glucose dialysis fluid (without RISA) to provide
data for calculation of the residual volume at 360 minutes.
The volume of the infused fresh dialysis fluid and the drained
dialysate were measured by weighing the bag and subtracting
the weight of the empty bag. Corrections for differences in the
specific weight of the solutions were not carried out.
The patients were instructed to sit up or to move about in bed
before each sampling of dialysate; otherwise they were recum-
bent throughout the six hour investigation. Informed consent
was obtained from each patient, and the study was approved by
the Ethical Committee of the Karolinska Institute at Huddinge
University Hospital.
Analytical methods
Blood and dialysate samples were analyzed for RISA activity
on an Intertechnique CG Gamma Counter (Intertechnique,
Plaisir, France). Glucose, urea, creatinine, and total protein
concentrations were measured with an IL 919 system (Instru-
mentation Laboratory, Milan, Italy), sodium and potassium
concentrations with an IL 743 flame photometer (Instrumenta-
tion Laboratory), and osmolality on a Wescor vapor pressure
osmometer (Wescor Inc., Logan, UT, USA).
Calculations
Intraperitoneal dialysate volumes (Vu) and net ultrafiltration
rates were estimated from the dilution of RISA with corrections
applied for the elimination rate of RISA from the peritoneal
cavity (KE, mi/mm) and sample volumes [2, 3, 14, 19]. The
diffusive mass transport coefficient (KBD) was calculated using
a one hour period of dialysate isovolemia [2, 3, 14], The
calculation of KBD-values were performed using the aqueous
concentration of the investigated solutes in plasma water, Cpw
[20]. was calculated from the measured whole plasma
concentration of investigated solutes (plasma concentration),
CBP, corrected for the plasma total protein concentration ac-
cording to the following formula [20, 211:
= u u = 1/(0.984 — 0.000718 U)
where is plasma total protein concentration in gfliter. In
this study, the time averaged value of plasma total protein
concentration during the dwell study was taken as Cprot. In the
dialysate, the corresponding correction for the measured con-
centration of investigated solutes was not carried out because of
the low dialysate concentration of protein 11.06 0.36 (sD)
glliter after 360 minI. The concentration of electrolytes (sodium
and potassium) in plasma water was corrected for the Donnan
factor by multiplication with the correction factor 0.96 [20, 21].
The measured concentration of creatinine in the dialysate was
corrected for the influence of glucose concentration in the
dialysate [22, 23] according to the formula:
Cereat = C'eat — 0.35 Cgiucose (2)
where Cereat is the corrected value of creatinine concentration;
C'r,t is the measured value of creatinine concentration (both
in mo1/liter); —0,35 is the correction factor obtained in our
laboratory; and Cgiucose is the concentration of glucose in the
dialysate at a given time (mmol/liter).
For the calculation of the peritoneal energy supply resulting
from absorption of glucose the value 3.85 kcal/g of anhydrous
dextrose absorbed was used [241.
For each of the three different glucose solutions the obtained
values of KD for each solute were used to calculate the amount
of solutes that would have been transported if diffusion had
been the only transport mechanism (Appendix). [Note that the
applied method for calculation of diffusive mass transport
coefficient involves a simple mathematical model in which we
by diffusion mean solute movement due to solute concentration
difference with constant transport coefficient (KBD), and in
which the peritoneal membrane is regarded as a membrane with
no active transport involved.] These data were compared with
the total intraperitoneal amount (MD) of solutes at each time
(t) calculated using the formula:
MD(t) D(t) (3)
where CD is the concentration of the solute in the dialysate. The
amount attributed to non-diffusive (that is, mainly convective)
transport was obtained by subtraction of the diffusive compo-
nent from the measured total amount of the solute. Note that
the homogeneous membrane models for peritoneal transport
imply that differences between overall and diffusive transport of
small solutes can be attributed only to convective transport.
However, the non-diffusive transport component may also
include lymphatic absorption, and possibly other transport
mechanisms. Thus, the current simplified approach to estimate
non-diffusive transport does not enable us to delineate the
details of peritoneal solute transport. On the other hand, the
lymphatic absorption may account for only a minor portion of
solute transport in peritoneal dialysis. Our previous calcula-
tions show that the impact of lymphatic flow on KED for small
solutes (estimated during dialysate isovolemia) is s5% if lym-
phatic flow is 1 mi/mm or less [141. Furthermore, there is no
evidence that transport mechanisms other than diffusion, con-
vective transport and lymphatic absorption contribute substan-
tially to peritoneal solute transport. Therefore, the presently
applied approach can be considered to provide an approximate
estimate of the relative importance of diffusive versus convec-
tive transport at different times of the dwell.
The initial intraperitoneal glucose amount (at time 0 mm) was
calculated as the sum of the amount of glucose in the bag prior
to infusion and the intraperitoneal amount of glucose in the
residual dialysate volume. The intraperitoneal amount of glu-
cose in the residual dialysate volume was calculated as the
product of the glucose concentration in the drained morning
dialysate and the estimated intraperitoneal residual volume at
360 minutes. The calculated amount of glucose in the residual
volume at time 0 minutes was on average 1.7 1.1% of the total
initial intraperitoneal amount of glucose.
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Fig. 1. Net ultrafiltration rate versus time and intraperitoneal dialy-
sate volume (mean SD) versus time during a six-hour single dwell
study with an exchange of 2 liter of 1.36% (N = 9, •), 2.27% (N 9,
or 3.86% (N = 23, A) glucose solution.
Statistical methods
Student's t-test for paired and unpaired data and calculation
of the correlation coefficient were used to evaluate the results.
When the three different glucose solutions were compared
analysis of variance (ANOVA) was used for single and repeated
measurements. When ANOVA single measurements showed
significant differences Scheffe's F test was used to further
analyze differences between groups. Data are expressed as
mean SD, unless otherwise noted. Statistical significance was
accepted if P < 0.05.
Results
Fluid transport
The intraperitoneal volume over time curves for the three
different glucose concentrations are presented in Figure 1
showing that the maximum intraperitoneal volume (Vmax,
Table 2) was higher and the time at which VDmax was obtained
(Tvmax) occurred later for solutions with a higher glucose
concentration. As seen in Figure 1, net ultrafiltration occurred
mainly during the first 15 minutes for the 1.36% dialysis fluid
and during the first 90 minutes for both the 2.27% and the 3.86%
dialysis fluid. The initial period of rapid net ultrafiltration (Fig.
1) was followed by a period of dialysate isovolemia (with
volume changes of less than 2% per hr) lasting between 15
minutes and 120 minutes of the dwell for the 1.36% solution,
between 90 and 240 minutes for the 2.27% solution, and
between 120 and 240 minutes for the 3.86% solution. Finally, a
period of net fluid reabsorption with a rate (Vr,/t, mean
values: 1.0 — 1.1 mi/mm; Table 2) independent of the initial
glucose concentration in the dialysis fluid was observed in each
of the 41 studies. As seen in Figure 1 the 2,27% glucose solution
provided a volume over time curve which was closer to that of
the 1.36% glucose solution curve than to that of the 3.86%
glucose solution.
The KE values were slightly higher for the 3.86% solution
than for the other two solutions (Table 2), indicating faster
elimination of RISA (P < 0.01, t-test between the 3.86% group,
N = 23, and the combined material of the 1.36% and 2.27%
group, N = 18). The fluid reabsorption rate between 240 and 360
minutes correlated both with KE (r = 0.532, P < 0.001) and with
the percentage of glucose absorbed at 360 minutes (r = 0.385, P
= 0.013).
Glucose transport
The dialysate glucose concentration (Fig. 2) as well as the
amount of glucose (Fig. 3) in the dialysate decreased exponen-
tially with time in a uniform way. The percentage of the amount
of glucose absorbed over time was almost identical for the three
solutions (Fig. 3). The mean percentage of the initial amount of
glucose which had been absorbed (%GA) at various times (t,
mm) during the dwell (from 3 to 360 mm) could be described (r
= 0.999) for all three solutions, using the experimental formula:
%GA = 85 — 75.7*e — O.005*t (4)
At the termination of the dwell study, about 75% of the initial
glucose amount had been absorbed for all three solutions (Fig.
3). Of the total amount of glucose absorbed about 50% was
absorbed during the first 90 minutes of the dwell (Fig. 3). The
corresponding peritoneal energy supply from glucose absorp-
tion for the three solutions is given in Table 3.
The energy load resulting from glucose absorption may
represent a metabolic problem in CAPD patients [16, 17]. From
a clinical point of view it may therefore be of value to achieve
the most effective fluid removal relative to energy load. The
ratio net ultrafiltration per kcal supplied from glucose absorp-
tion from the dialysate for the three different solutions was
highest at the beginning of the dwell and higher for the more
hypertonic solutions (Fig. 4). The net ultrafiltration per kcal
ratio decreased linearly after 90 to 120 minutes for all three
solutions. The ratio was 2.4 3.6 ml/kcal, 3.9 1.7 mllkcal and
5,1 2.8 ml/kcal at 120 minutes, and —1.7 2.8 mi/kcal, 1.1
1.4 ml/kcal and 2.6 1.5 ml/kcal at 360 minutes for the 1.36%,
2.27% and 3.86% solution, respectively.
Blood glucose concentrations remained essentially stable
with the 1.36% solution and showed only minor increases
during the first hour for the 2.27% and 3.86% solution with the
most pronounced increase for the 3.86% glucose solution [5.6
mmol/liter (N = 23) at 0 mm vs. 7.6 1.3 mmol/liter (N = 17,
P < 0.001) at 60 mm].
The diffusive mass transport coefficient (KBD) for glucose did
not differ between the three solutions (Table 4).
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Table 2. Fluid transpoii characteristics
N
V0 max
ml
max
mm
V3 VOUT —zSV1Ját K
ml mi/mitt
1.36%
2.27%
3.86%
9
9
23
2427 l27C
2642 J35C
3161 231
92 39l
160 94
197 74
2157 235C
2429 184C
2997 262
1930 224C
2211 179C
2612 242
227
218
385
117
iioa
194
1.1 0.7
1.0 0.7
1.0 0.9
1.2 0.3
1.2 0.6
1.7 0.6
Data are means SD. Abbreviations: VD max, maximum intraperitoneal dialysate volume; Tymax, time to reach V max; intraperitoneal
dialysate volume at 360 mm; VOUT, recorded dialysate effluent volume; VRES, residual intraperitoneal volume at 360 mm; —AV0ISt, rate of net
fluid reabsorption between 240 and 360 mm; K, elimination rate of RISA from the peritoneal cavity.
Significant differences for the 1.36% group and the 2.27% group, respectively, vs. the 3.86% group are marked: a Pc o,o, b P C 0.01, p <
0.001. Significant differences for the 1.36% group vs. the 2.27% group are marked: ii P <0.05
Transport of other solutes
The KBD values for urea, creatinine, potassium and total
protein did not differ between the three solutions (Table 4).
Note that KBD for sodium was calculated only for the 3.86%
glucose solution (Table 4) because for the 1.36% and 2.27%
glucose solution the change in dialysate sodium concentration
during dialysate isovolemia (Fig. 5) was too small to allow a
reliable calculation of Kan for sodium. The use of aqueous
solute concentrations (Methods) in the calculations of
yielded much lower values of Knn for small solutes (with the
exception of glucose) in comparison to values calculated
using non-corrected plasma solute concentrations. In the cur-
rent study the difference was found to be about 40% for urea,
20% for creatinine and 10% for potassium (data not shown).
There were small but statistically significant differences in
KBD values for total protein and creatinine between the patients
with and the patients without previous peritonitis episodes,
respectively. The KED values were: for total protein 0.116
0.068 versus 0.069 0.039 mllmin (P < 0.05), and for creatinine
11.6 4.8 versus 8.5 3.9 mllmin (P C 0.05) for the patients
with (N = 17) and without (N = 16) previous peritonitis
episodes respectively. However, there was no difference be-
tween the two groups as regards KBD values for glucose, urea
and potassium, nor as regards KE, intraperitoneal dialysate
volume curves, and fractional glucose absorption.
The dialysate sodium concentration decreased during the first
90 minutes with the most marked changes for the 3.86%
solution whereas the dialysate potassium concentration did not
differ between the three solutions (Fig. 5).
Plasma potassium, urea and creatinine concentrations re-
mained essentially stable during the dwell study (data not
shown) whereas the plasma sodium levels showed a slight
increase when the 3.86% glucose solution was used (from 139.4
2.7 mmol/liter at 0 mm to 140.3 2.4 mmol/liter at 360 mm,
P < 0.01, t-test). Plasma total protein decreased slightly during
the dwell when the 1.36% and 2.27% solutions were used (from
67.8 5.3 and 68.3 6.6 g/liter at 0 mm to 64.1 4.9 and 64.3
6.4 g/liter at 360 mm, respectively, P C 0.05 and C 0.001,
t-test) possibly due to positive fluid balance and dilution of the
plasma concentration. During the use of the 3.86% solution,
plasma total protein levels remained stable (65.4 4.4 and 65.5
5.5 g/liter at 0 and 360 mm, respectively; NS).
The dialysate osmolality showed the same pattern as the
dialysate glucose concentration (Fig. 6).
Calculated amounts transported by djffusion only
The methods for the assessment of the diffusive and non-
diffusive components of solute transport are described in the
Appendix. The total intraperitoneal amount of solutes over time
in the dialysate was calculated for total protein (Fig. 7), glucose,
creatinine, urea, potassium and sodium for each of the three
solutions. The intraperitoneal amounts were compared with the
calculated amounts, which according to equation A2 in the
Appendix, may be assumed to have been transported by diffu-
sion only (Figs. 8 and 9). The relative importance of non-
diffusive transport vs diffusive transport was largest during the
initial part of the dwell with the 3.86% glucose solution in which
case non-diffusive transport after 60 minutes of dwell time
accounted for about 30 to 40% of the total peritoneal transport
of urea (29 13%), creatinine (27 16%) and potassium (40
18%) (Fig. 8). The non-diffusive transport was less important
for the 2.27% glucose solution and negligible for the 1.36%
glucose solution (data not shown). Paradoxically the calculated
net glucose disappearance rate from the peritoneal cavity was
faster than the calculated rate due to diffusion only (Fig. 9); the
calculated non-diffusive glucose transport was thus negative.
This phenomenon was observed for all three glucose solutions.
Discussion
This is the first study which provides a detailed comparative
analysis of peritoneal fluid and solute transport characteristics
for the three most widely used glucose-based dialysis solutions
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Fig. 2. Intraperitoneal dialysate glucose concentration (mean so)
versus time during a six-hour single dwell study with 2 liter of 1.36%,
2.27% or 3.86% glucose solution. Symbols as in Fig. I.
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Fig. 3. Intraperitoneal dialysate glucose (%
of initial amount, mean SD) and percentage
of glucose amount absorbed versus time
during a six-hour single dwell study with 2
liters of 1.36%, 2.27% or3.86% glucose
solution. Symbols as in Fig 1.
Table 3. Amount of glucose absorbed and corresponding peritoneal energy load at different times of the dwell (mean SD)
N 30 mm 60 mm
Amount of glucose absorbed g
90 mm 120 mm 180 mm 240 mm 360 mm
1.36%
2.27%
3.86%
9 6±1 8±1
9 10±3 15±4
23 15±4 24±5
11±2 12±2 15±2
18±4 21±4 25±5
29±5 34±6 41±6
17±2
29±5
48±7
20±2
35±5
56±7
N 30 mm 60 mm
Pentoneal energy load kcala
90 mm 120 mm 180 mm 240 mm 360 mm
1.36%
2.27%
3.86%
9 23±5 33±5
9 38 11 56 14
23 59 14 93 18
41±7 47±6 58±7
68 14 81 14 98 17
112 21 130 23 159 25
65±7
113 18
183 27
78±6
135 19
217 26
a Energy of anhydrous dextrose: 3.85 kcallg 124]
in CAPD patients. Special attention was paid to assure accurate
intraperitoneal volume measurements as well as accurate deter-
minations of solute transport parameters during a period of
dialysate isovolemia, using aqueous solute concentrations. An
attempt was made to quantitatively assess the relative impor-
tance of diffusive versus non-diffusive transport of small sol-
utes. In the current study the intraperitoneal dialysate volume
over time curve (Fig. 1) was characterized by the rate and
duration of the initial positive net ultrafiltration (depending on
the glucose osmotic pressure), the duration of dialysate iso-
volemia (long-lasting for the three solutions) and finally by the
rate of fluid reabsorption (similar for all three solutions). The
diffusive mass transport properties of the peritoneum did not
seem to depend either on the initial dialysate concentration of
glucose or on the ultrafiltration flow rate. The results of the
present study indicate that although for small solutes diffusion
is the dominating transport mechanism, non-diffusive (that is
mainly convective) transport of small solutes contributes sub-
stantially to the overall peritoneal transport during the initial
part of an exchange with hypertonic dialysis fluid; an alternative
explanation could be that KBD is variable and perhaps higher at
the beginning of the dwell leading to overestimation of the
non-diffusive transport component (vide infra).
Fluid transport
During the initial part of the dwell, net ultrafiltration (flow
rate as well as duration) differed substantially between the three
investigated dialysis solutions. The maximum initial (3 to 15
mm) net ultrafiltration rate, which showed large interpatient
variability, was found to be on the average 6 ml/min, 8 ml/min
and 14 ml/min, respectively, with the three investigated solu-
tions. Note the rapid fall of net ultrafiltration rate during the
beginning of the dwell for all three solutions (Fig. 1). This
change reflects the rapid dissipation of the osmotic driving
force; however, other factors such as a change of the hydraulic
conductivity of the pentoneal barrier can not be ruled out. In
additiqn, incomplete mixing of the dialysate may result in a
small but systematic underestimation of the volume at three
minutes. The period of dialysate isovolemia was found to be
long-lasting for all three solutions. The fluid reabsorption rate
between 240 and 360 minutes was of the same magnitude, about
1 mI/mm. During the entire period of fluid reabsorption there
was still a positive glucose osmotic gradient. This gradient is
counterbalanced by the colloid osmotic pressure, the hydro-
static pressure and the lymphatic flow [6, 25—29]. In fact, the
model proposed by Rippe et al [27—29], which takes into
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account these phenomena, generates theoretical dialysate vol-
ume over time curves [29] which are in excellent agreement
with the results of the current study.
The 2.27% glucose solution provided a volume over time
curve which was surprisingly close to the volume curve of the
1.36% glucose solution. The present results suggest that a new
medium strength glucose solution with a concentration of
glucose between 2.27% and 3.86%, yielding an intermediary
volume curve could be clinically more valuable than the current
2.27% glucose solution for the management of fluid balance in
CAPD patients.
In most previous studies, the evaluation of volume over time
profiles was either made without a tracer, or the disappearance
rate of the tracer was not taken into account, leading to large
errors in the determination of the dialysate volume at the end of
the dwell [19, 301. The volume over time profiles found in the
current study are in agreement with previous studies in which
dialysate volume assessments were based on measurements of
the drained volume at different times of a single dwell [28] or on
different dwell periods [31, 321 or using RISA [331, unlabelled
albumin [341 or autologous hemoglobin [33, 35—371 as volume
markers. However, there are only a few previous reports
comparing intraperitoneal dialysate volume over time curves in
CAPD patients using different glucose solutions [28, 31, 32];
none of these studies involved more than two different glucose
concentrations.
In the current study the tracer disappearance rate (Ks) was
assumed to be by first order kinetics, that is, KE is constant and
the amount of tracer eliminated from the peritoneal cavity is
proportional to the dialysate concentration of the tracer. In
some previous studies corrections for tracer elimination, as-
suming zero order kinetics was applied, that is, the amount of
tracer removed per time unit was assumed to be constant and
not influenced by the dialysate tracer concentration 136, 38].
This assumption is hard to defend from a theoretical point of
view since it would suggest that the tracer elimination rate
depends reciprocally on the tracer concentration in the dialy-
sate. However, the application of zero versus first order kinet-
ics of tracer elimination results in almost identical dialysate
volume over time curves.
The elimination rate of RISA (KE), which is an estimate of
albumin transport from the peritoneal cavity into the lymphatics
and into adjacent tissues, was found to be similar to previously
reported values of tracer elimination rate using unlabelled
albumin [34], RISA [39], dextran [40] and autologous hemoglo-
bin [36, 37, 39] as volume markers. In the current study K was
slightly higher for the 3.86% solution than for the two weaker
solutions. Lymphatic absorption is known to be influenced by
hydrostatic pressure [25, 41] and it is possible that the larger
dialysate volume, and thus increased hydrostatic pressure [42]
during peritoneal dialysis with the 3.86% solution may increase
the lymphatic absorption of fluid (and perhaps also increase
losses of RISA into adjacent tissues). The hypothesis that the
hydrostatic pressure can have an impact on the rate of lym-
phatic absorption is also in line with the previous observation
that the tracer elimination rate is higher during a three liter
exchange compared to a two liter exchange with 1.36% glucose
solution [36]. Volume calculations using first order kinetics with
constant tracer elimination coefficient could therefore result in
a slight error in the determination of dialysate volume.
In the current study, KE and the fluid reabsorption rate were
of the same order of magnitude, 1 to 2 mI/mm (Table 2), and
there was a positive correlation between these two variables.
This may suggest that K and the fluid reabsorption rate reflect
lymphatic absorption [43]. However, the magnitude of the
lymphatic flow rate in CAPD patients is controversial [44—47]
since the appearance rate of the tracer in blood is only 10 to 20%
of the disappearance rate from the peritoneal cavity [40, 48—51].
Diffusive solute transport
For the calculation of the diffusive mass transport coefficient
(KBD) plasma small solute concentrations were expressed as
aqueous solute concentrations, that is corrected for plasma
protein concentration, and for electrolytes also with a correc-
tion applied for the Donnan factor. This correction resulted in
KBD values which were substantially smaller than KBD values
obtained using plasma solute concentrations for all the investi-
gated small solutes except glucose. The difference was espe-
cially large for urea, for which was on average about 40%
lower compared to uncorrected values. These results show the
importance of using aqueous instead of plasma solute concen-
trations for KnD calculations for substances which equilibrate
rapidly [20].
The diffusive mass transport parameter (KED) for small
solutes did not differ between the three solutions, indicating
that the diffusive transport properties of the peritoncal mem-
brane were not influenced by the three solutions. Thus, no
impact of different volumes or glucose concentrations within
the investigated range could be demonstrated. However, a
small difference in KBD values between the different glucose
solutions cannot be excluded since the same patients were not
studied with the three different solutions. It is also possible that
volume differences at the time of dialysate isovolemia were too
small to demonstrate a possible influence of dialysate volume
on (isovolumetric) KBD. In the previous study by Spencer and
Farrell [40] concerning the possible influence of dialysate
volume and glucose concentration on KBD values for urea and
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Fig. 4. The mean ratio net ultrafiltration per energy supplied from
glucose absorbed from the dialysate (Net UFIi.p. energy supply,
ml/kcal) versus time during a six-hour single dwell study with 2 liters of
1.36%, 2.27% or 3.86% glucose solution. Symbols as in Fig. 1.
Time, minutes
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Table 4. Diffusive mass transport coefficients (K0) for investigated substances (mean SD)
1327
N
KBD mi/mm
Glucose Urea Creatinine Sodium Potassium Total protein
1.36% 9 9.6 3.7 18.1 3.5 12.4 3.9 NC 13.6 4.3 0.10 0.03
2.27% 9 10.7 2.7 17.0 4.0 10.2 4.5 NC 14.8 6.6 0.11 0.09
3.86% 23 10.6 2.5 17.1 3.2 9.3 4.2 4.6 2.6 10.4 4.6 0.08 0.04
NC = Not calculated because the change in dialysate sodium concentration during dialysate isovolemia (Fig. 6) was too small to allow a reliable
calculation of KBD for sodium.
Statistical analysis (ANOVA) showed no statistically signifiant difference in KBD values for the investigated substances between the three
different glucose dialysis solutions.
creatinine, a higher KBD for urea but not for creatinine was
found in twelve CAPD patients studied with a two liter ex-
change of 1.36% glucose solution compared to a one liter
exchange. In a study comparing two and three liter exchanges
with 1.36% glucose solutions, Krediet et al [36] found signifi-
cantly higher peritoneal mass transfer area coefficients for
creatinine, kanamycin and inulin using the larger volume but no
difference for urea, lactate, glucose, /32-microglobulin, albumin
or IgG. Furthermore, no difference in KBD for urea and
creatinine between 1.36% and 3.86% glucose solutions was
found in five CAPD patients investigated [40]. The use of a 7%
Time, minutes
Fig. 7. The measured intraperitoneal amount of total protein (mean
SD) versus time during a six-hour single dwell study with 2 liters of
1.36%, 2.27% or 3.86% glucose solution. Symbols as in Fig. I.
glucose solution for peritoneal dialysis in uremic patients has
been associated with an increased solute clearance which
exceeded the possible contribution of convective transport [52]
and this effect was still observed in lesser degree during a
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Fig. 5. Dialysate potassium and sodium concentration (mean SD)
versus time during a six-hour single dwell study with 2 liters of 1.36%,
2.27% or 3.86% glucose solution. Symbols as in Fig. 1.
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Fig. 6. Dialysate and plasma osmolality (mean SD) versus time
during a six-hour single dwell study with 2 liters of 1.36%, 2.27% or
3.86% glucose solution. Dialysate symbols as in Fig. 1. Plasma symbols
are: 1.36% (N = 9, •), 2.27% (N = 9, O) and 3.86% (N = 23, A).
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Fig. S. The measured total intraperitoneal amount (D), the calculated amount that would have been transported if diffusion had been the only
transport mechanism (A) and the calculated amount transported due to non-diffusive transport (•) for urea, creatinine, sodium and potassium
in patients studied with 3.86% glucose solution (mean so, N = 23).
subsequent exchange of isotonic dialysis fluid [52, 53J. How-
ever, such an effect was not seen in rabbits studied with 4.25%
and 1.25% glucose solution [54].
The observed decrease of dialysate sodium during the initial
period of rapid ultrafiltration (Fig. 5), indicates sodium sieving
through the peritoneal barrier [12, 13, 20]. The finding that
dialysate sodium concentration decreases substantially with the
hypertonic 3.86% glucose solution and that plasma sodium
concentration increases slightly, indicate that very short dwell
times with hypertonic glucose solution may lead to low sodium
removal relative to fluid removal. This may result in hyperna-
tremia [55], especially in patients treated with rapid exchanges
of hypertonic glucose solution with a cycler. To avoid this
dialysis fluid with lower sodium concentration may be of value.
Non-diffusive solute transport
The estimated non-diffusive transport (which mainly should
consist of convective transport) contributes substantially to the
overall transport of creatinine, urea, potassium and sodium
during the initial period of the exchange with 3.86% glucose
solution (Fig. 8). Thus, the convective transport plays an
important role in enhancing net peritoneal clearance for these
solutes when hypertonic solutions and short dwell periods are
used [7]. Note that the postulated existence of a peritoneal
tissue compartment (vide infra) could result in variable K4,
values during the dwell. Therefore, the application of models in
which KBD is assumed to be constant may not be appropriate
for the correct estimation of non-diffusive transport.
Although KBD for total protein was calculated during a period
of dialysate isovolemia, the phenomenological parameter KnD
does not exclude the possibility that convective transport is the
dominating feature of transperitoneal macromolecular trans-
port. There is strong evidence that transcapillary exchange of
macromolecules is mainly by convective transport through
large pores [56—58]. Therefore an estimation of the relative
importance of diffusive versus non-diffusive transport was not
carried out for total protein in the current study. However, the
finding that the intraperitoneal amount of total protein was
almost identical over time with the three different glucose
solutions (Fig. 7) indicates that transport of total protein
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Fig. 9. The measured total intraperitoneal amount of glucose (E1) and
the calculated amount of glucose in the peritoneal cavity when glucose
transport was calculated to be by diffusion only (A) in patients studied
with 3.86% glucose solution (mean SD, N = 23). Note that glucose
disappears faster from the peritoneal cavity than expected from diffu-
sion only.
through the peritoneal barrier is not influenced by the differ-
ences in glucose concentration or ultrafiltration rate.
Glucose transport
The fractional glucose absorption, expressed as a percentage
of the initial intraperitoneal amount of glucose, was almost
identical for all three solutions (Fig. 3), and similar to previous
observations in patients using different dwell times and different
glucose solutions [5, 59, 601. The absorbed amount of glucose
provides a substantial energy supply (Table 3). Thus, a patient
using four 1.36% two liter bags will absorb about 80 g glucose/24
hr corresponding to 300 kcalI24 hr and a patient using four
3.86% two liter bags will absorb about 220 g glucose/24 hr
corresponding to 850 kcalI24 hr. This is in keeping with the
reported average daily absorption of 100 to 200 g glucose in
CAPD patients [61—65]. Patients with decreased ultrafiltration
capacity need more frequent exchanges with hypertonic solu-
tions. In addition, the glucose absorption rate is often increased
in these patients [14], resulting in an even larger peritoneal
caloric load.
The relationship between net ultrafiltration and the peritoneal
energy load from glucose absorption (Fig. 4) shows that the net
fluid removal per kcal supplied from glucose absorption was
highest with the 3.86% glucose solution compared to the less
hypertonic solutions (Fig. 4). Thus, to achieve the most effec-
tive fluid removal relative to glucose absorption, hypertonic
glucose solutions with short dwell times should be used; how-
ever, this may result in hypernatremia (vide supra) as well as in
hyperglycemia [1, 17].
The observation that the fractional absorption of glucose was
almost identical for the three solutions, indicates that the
peritoneal transport of glucose is mainly by diffusion and thus
that convective transport of glucose plays only a minor role.
Note that during positive ultrafiltration the fluid flow is from
blood to dialysate which is in the opposite direction than the net
diffusive transport of glucose from dialysate to blood. Since the
concentration of glucose in the ultrafiltered fluid (osmotically
driven from blood) is much smaller than in the dialysate, this
fluid flux should diminish the rate of glucose diffusion from the
peritoneal cavity to blood. In contrast, the calculated net
glucose disappearance rate from the peritoneal cavity was
faster than the estimated rate due to diffusion only (Fig. 9) and
the calculated non-diffusive glucose transport was thus negative
for all three glucose solutions. This paradoxical observation is
in agreement with our previous theoretical evaluation using the
Pyle-Popovich model [12, 20]. When using glucose as osmotic
agent the sieving coefficient for glucose (calculated using the
Pyle-Popovich model) was found to be negative (that is, out of
the physically interpretable range), indicating that glucose is
transported faster from the peritoneal cavity than expected
from the KBD values obtained with the model [12, 20]. Thus, the
results of the current study as well as the previous application
of the Pyle-Popovich model [12, 20] shows that, although
peritoneal transport models in which the peritoneal barrier is
regarded as a homogeneous membrane can give a proper
description of peritoneal solute transport for clinical purpose
[12], they cannot provide a theoretically correct description of
glucose transport at least when glucose is used as osmotic agent
in the dialysis fluid. Similarly, in the application of the three-
pore model in which theoretical and literature data were used to
fit experimental data to the calculated volume over time curve
for different glucose solutions, Rippe, Stelin and Haraldsson
[29] had to introduce inflated KBD values for glucose in order to
obtain a reasonably good fit of simulated to experimental data.
In the study by Rippe et a!, the assumed KBD value for glucose
was increased by about 50%, to 15.5 mi/mm, from the theoret-
ically predicted value of 10.2 mI/mm [29]. Note that the KBD
value for glucose predicted by Rippe et al [29], 10.2 mllmin, is
similar to the value found in the current study (Table 4) and in
agreement also with previously reported data for clinically
stable CAPD patients [6, 38, 66—68].
The puzzling observation in the current study that glucose
disappearance from the peritoneal cavity was faster than ex-
pected (from the calculated rate of diffusion of glucose), espe-
cially during the initial part of the dwell (Fig. 9), may perhaps be
related to the postulated existence of a peritoneal tissue com-
partment in which the concentrations of solutes are equilibrat-
ing (with some time lag) with the dialysate compartment [19,
69]. This process may result in higher values during the
beginning of the dwell [29, 70]. Furthermore, active transport of
glucose into cells (where it is metabolized) is not taken into
account in currently used peritoneal transport models. Due to
rapid glucose absorption, the average blood glucose concentra-
tion in the capillaries surrounding the peritoneal cavity is
probably higher than the concentration in systemic blood used
for the calculation of KBD for glucose. Such a discrepancy
would lead to an underestimation of the diffusive mass transport
coefficient (K) for glucose. However, the problem of appar-
ent negative non-diffusive glucose transport remains unsolved.
Summary and conclusions
During a six-hour peritoneal dialysis dwell with standard
glucose-based dialysis fluids, the rate and duration of initial
positive net ultrafiltration was proportional to the dialysate
glucose concentration (Table 2, Fig. 1). The fluid reabsorption
rate, however, did not differ between the three investigated
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solutions (Table 2, Fig. 1), indicating that it was not influenced
by the dialysate glucose concentration and that the combined
effect of the three major determinants of the peritoneal fluid
reabsorption rate (the colloid osmotic pressure, the hydrostatic
pressure and the lymphatic flow rate) was constant. The hyper-
tonic dialysis fluids provide a substantial peritoneal energy
supply from absorption of glucose from the dialysate (Table 3,
Figs. 2 and 3). On the other hand, to achieve maximum net
ultrafiltration relative to glucose absorption (Fig. 4), hypertonic
solutions with short dwell times should be used. This may result
in hyperglycemia, as well as in hypernatremia due to the more
rapid fluid relative to sodium transport rate through the perito-
neat barrier (Fig, 5), but during a six hour dwell the effect of
hypertonic solutions on plasma osmolality is negligible (Fig. 6).
The KBD values for urea, creatinine, glucose, potassium and
total protein did not differ between the three different solutions
(Table 4), and the fractional absorption of glucose was almost
identical (Fig. 3), indicating that the diffusive transport proper-
ties of the peritoneum does not depend on the diatysate con-
centration of glucose or on the ultrafiltration flow rate. The
intraperitoneal appearance rate of total protein was almost
constant and did not differ between the three solutions (Fig. 7).
The calculated non-diffusive (that is, mainly convective) trans-
port of small solutes (other than glucose) was found to be
substantial during the initial part of an exchange with hyper-
tonic solution and accounted for about 30 to 40% of the total
transport of urea, creatinine and potassium during the first 60
minutes of the 3.86% exchange (Fig. 8). Paradoxically the
calculated non-diffusive transport for glucose was found to be
negative (Fig. 9), indicating that glucose is transported faster
from the peritoneal cavity than would be expected from diffu-
sion only. This suggests that peritoneal transport models based
on passive transport through the homogeneous membrane with
constant diffusive mass transport coefficient (KBD) cannot
provide a theoretically correct description of glucose transport
at least when glucose is used as osmotic agent in the dialysis
fluid, Thus, the applied methods have helped us to identify an
inherent problem in the clinically used models based on these
assumptions [2, 3, 6, 8—14, 35—38, 40, 52, 66—68].
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Appendix
Assessment of djffusive and non-diffusive components of
solute transport in peritoneal dialysis
The total amount of a solute, MD, in the dialy sate is a product
of the solute concentration, C0, and the dialysate volume, VD,
that is, MD CDVD. The rate of change of MD, dMD/dt, is equal
to the net flow of solute between blood and dialysate. This flow
consists of three components: 1) diffusive flow which is propor-
tional to differences between concentrations of the solute in
blood, CB, and dialysate, C0, with KBD as the coefficient of
proportionality; 2) convective flow which is dependent on
ultrafiltration rate, concentration of the solute in the membrane
and sieving coefficient; and 3) lymphatic uptake which is
dependent on the lymphatic flow rate and CD [6, 12]. The
lymphatic uptake accounts for a relatively minor fraction of the
total peritoneal transport of solutes [12, 141 and this transport
route is neglected in the following calculations.
To assess the relative importance of the diffusive and con-
vective components in peritoneal mass transport a stepwise
procedure was applied in which we first considered the diffusive
transport only. A hypothetical situation was assumed that
solutes are transported by diffusion only in spite of the water
flow between blood and dialysate resulting in convective trans-
port of solutes. Thus we applied the following equation:
dM0/dt = KHD(CB — CD) (Al)
where CD = M0/V0. Analytical solution of equation (Al) for
constant CB and V can be expressed as follows:
MD(t2) = CBVD + (M0(t1) — CBVD)exp (A2)
( — K(t — tj)/VD)
for time interval from t1 to t2. The assumption of relatively
constant blood concentrations of the investigated solutes was
fulfilled in this study for the whole dwell time, whereas dialy-
sate volume changed significantly especially in dwell studies
with hypertonic solution. Therefore we applied equation (A2)
for each time interval between two consecutive measurements
at 3, 15, 30, 60, 90, 120, 180, 240, and 360 minutes, respectively,
taking D equal to the arithmetic average of the dialysate
volume for the particular interval. The maximum change of VD
during these time intervals was lower (on average 6.8% for the
3.86% glucose solution between t1 = 3 mm and t2 15 mm)
than the change of V0 during whole dwell study (on average
21.9%, Fig. 1).
The value of M0 calculated from equation (A2) for KBD
estimated during dialysate isovolemia was assumed to represent
the fraction of solute amount in dialysate that would be a result
of diffusive transport. The amount of the solute that can be
attributed to non-diffusive (convective) transport was then
obtained by subtracting the diffusive component [equation (A2)J
from the experimentally-found total amount of the particular
solute.
The justification for this approach to assess non-diffusive
transport is that the mathematical models for peritoneal trans-
port in which simultaneous diffusive and convective transport
parameters are estimated, may yield unphysiological values of
the convective transport coefficient of proportionality; thus the
sieving coefficient for some substances have been found to be
negative or exceed one [12].
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